20/20 GeneSystems cover feature

20/20 GeneSystems

Early-stage cancer detection
$5,072,081 Raised
Ended February 16th
It is unfortunate that we often hear about someone who goes to their doctor with what seems like an innocuous symptom only to be diagnosed with a advanced stage cancer. This is all too common because many cancers present without obvious symptoms until they progress into the later stages of development and become difficult or impossible to effectively treat. However, early detection can be key to better treatment outcomes and long-term survival. Cancer is the...
Learn more about this company

Other popular startups

Get email updates for the latest investment opportunities